Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 7,142 | 10,296 | 10,953 | 11,630 | 10,245 |
| Operating Income | -7,142 | -10,296 | -10,953 | -11,630 | -10,245 |
| Other Income | -366 | -322 | -667 | -460 | 360 |
| Pre-tax Income | -7,508 | -10,618 | -11,620 | -12,090 | -9,885 |
| Net Income Continuous | -7,508 | -10,618 | -11,620 | -12,090 | -9,885 |
| Net Income | $-7,508 | $-10,618 | $-11,620 | $-12,090 | $-9,885 |
| EPS Basic Total Ops | -3.47 | -4.90 | -5.36 | -3.35 | -4.40 |
| EPS Basic Continuous Ops | -3.47 | -4.90 | -5.36 | -3.18 | -4.59 |
| EPS Diluted Total Ops | -3.47 | -4.90 | -5.36 | -3.35 | -4.40 |
| EPS Diluted Continuous Ops | -3.47 | -4.90 | -5.36 | -3.18 | -4.59 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -5.60 | N/A |
| EBITDA(a) | $-6,814 | $-10,032 | $-10,631 | $-11,306 | $-9,876 |